Status:
UNKNOWN
Determinant of Fetal Growth Retardation After Sleeve Gastrectomy: Involvement of Ghrelin
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
In Utero Growth Retardation
Sleeve Gastrectomy
Eligibility:
FEMALE
Brief Summary
The aim of the study is to determine, in pregnant women who have undergone sleeve gastrectomy (SG), whether ghrelin changes could be involved in in utero growth restriction (IUGR) and whether therefor...
Detailed Description
Bariatric surgery (BS) has developed rapidly in recent years and the candidates are predominantly women of childbearing age. A negative impact on fetal growth (FG), has been described after BS whose m...
Eligibility Criteria
Inclusion
- Woman previously operated of sleeve gastrectomy
- Pregnant from 3 to 6 months
- Having a mono-fetal pregnancy
- Coming to consult in day hospital for a nutritional assessment
Exclusion
- Twin pregnancy
- Identified cause of IUGR apart from those related to sleeve gastrectomy
- Woman who has undergone another bariatric surgery technique
- Lack of individual information and collection of the consent form
- Problems of understanding
- Lack of affiliation to a social security scheme or state medical aid
- Patient benefiting from a legal protection measure (with guardians or curators)
Key Trial Info
Start Date :
July 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05977790
Start Date
July 10 2023
End Date
July 1 2025
Last Update
August 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Louis Mourier
Colombes, France, 92025